共 50 条
- [32] ALVIMOPAN IS ASSOCIATED WITH A REDUCTION IN LENGTH OF STAY AND HOSPITAL COSTS FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E1196 - E1196
- [33] ALVIMOPAN, A PERIPHERALLY ACTING MU-OPIOID RECEPTOR ANTAGONIST, ACCELERATES GASTROINTESTINAL RECOVERY AND DECREASES LENGTH OF HOSPITAL STAY AFTER RADICAL CYSTECTOMY [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E767 - E767
- [35] METFORMIN USE IN DIABETIC MEDICARE BENEFICIARIES IS ASSOCIATED WITH IMPROVED SURVIVAL FOLLOWING RADICAL CYSTECTOMY [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E945 - E945
- [37] THE NOVEL OPIOID RECEPTOR ANTAGONIST ALVIMOPAN MINIMIZES POST-OPERATIVE ILEUS FOLLOWING RADICAL CYSTECTOMY [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E643 - E644
- [38] IS COMPLIANCE TO AN ENHANCED RECOVERY PROTOCOL AFTER RADICAL CYSTECTOMY ASSOCIATED WITH IMPROVED POST OPERATIVE OUTCOMES? [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E1127 - E1129